Prime Medicine Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	629	862	1,806	-
Market Cap Growth	-29.81%	-52.26%	-	-
Enterprise Value	456	741	1,527	-272
PE Ratio	-	-4.35	-12.72	-
PS Ratio	1077.43	-	-	-
PB Ratio	2.61	6.48	5.71	-
P/FCF Ratio	-4.19	-4.95	-12.21	-
P/OCF Ratio	-4.38	-5.21	-13.70	-
EV/Sales Ratio	772.14	-	-	-
EV/EBITDA Ratio	-3.54	-4.09	-13.79	1.69
EV/EBIT Ratio	-3.22	-3.73	-12.44	1.64
EV/FCF Ratio	-3.29	-4.25	-10.33	7.12
Debt / Equity Ratio	0.18	0.10	0.09	-0.07
Debt / EBITDA Ratio	-0.24	-0.08	-0.26	-0.06
Debt / FCF Ratio	-0.22	-0.08	-0.19	-0.27
Quick Ratio	9.17	2.40	11.51	4.88
Current Ratio	8.90	2.53	11.10	4.67
Asset Turnover	0.00	0	0	0
Return on Equity (ROE)	-100.90%	-93.70%	-177.50%	239.30%
Return on Assets (ROA)	-79.80%	-76.90%	-42.90%	-103.30%
Return on Capital (ROIC)	-74.11%	-139.60%	-33.78%	57.92%
Earnings Yield	-32.12%	-22.98%	-7.86%	-
FCF Yield	-31.50%	-20.19%	-8.19%	-
Buyback Yield / Dilution	-17.29%	-168.42%	-161.23%	-391.47%
Total Shareholder Return	-17.29%	-168.42%	-161.23%	-391.47%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).